In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study
about
Avibactam and Class C -Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for ResistanceAntimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) programCeftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Reversing resistance: The next generation antibacterials.Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in TaiwanThe Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic modelEscherichia coli sequence type 131: epidemiology and challenges in treatment.Natural product and natural product derived drugs in clinical trials.Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.Treatment of Staphylococcus aureus Infections.Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.Genome sequencing and analysis of the first spontaneous Nanosilver resistant bacterium Proteus mirabilis strain SCDR1.Pharmacokinetics of penicillin G in preterm and term neonates.
P2860
Q27684678-EB60211D-7E61-4284-8051-73584EBBA9F7Q34174397-C3C58C4A-FE66-481A-9398-F5E1152C3576Q34402134-8C697AC5-967D-49D3-AA83-7C7230EBF1E5Q35482558-00F7D60D-FFFC-43C6-9C4E-4C2A254B883BQ35669688-A967D70E-7B27-4A84-9959-4E0188B3A4EEQ35859801-33531E98-976E-4FC5-A523-3E3E86833CD6Q37400286-B5520C09-FAF5-48EB-BDC8-87CCC9735E35Q37544518-5213D376-6542-49D9-8BA3-5FCCD220EC0DQ38201515-F0FA5027-DA8A-418A-BBE3-87D46A58DD5EQ38247457-10215B80-CA65-4DCE-9C23-4472A50987DAQ38648594-3EBCDCE3-EB0B-4843-AC5D-BFBF6683BBD4Q38892589-7CD98D68-E2AB-4170-867E-66EF743EE239Q38981397-FEA04A15-5854-45EB-80A9-7C8E3E8E4BD4Q40049973-FA032116-32AF-4F12-B3BA-2283758E57FCQ41665025-D3F9AC3E-B8E9-4F68-9A7C-4457126BDFC8Q43144149-00FA52F7-3272-4932-A85D-815D297B06F5Q46256441-998180A1-D719-43B1-A332-B93097DA78B7Q47115659-6354EA05-C5D5-4E0A-B27D-4AF260C1F868Q49791998-428B0353-B9BD-46D6-8988-909C62434BC5
P2860
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of ceftaroli ...... the CANWARD surveillance study
@en
In vitro activity of ceftaroli ...... he CANWARD surveillance study.
@nl
type
label
In vitro activity of ceftaroli ...... the CANWARD surveillance study
@en
In vitro activity of ceftaroli ...... he CANWARD surveillance study.
@nl
prefLabel
In vitro activity of ceftaroli ...... the CANWARD surveillance study
@en
In vitro activity of ceftaroli ...... he CANWARD surveillance study.
@nl
P2093
P2860
P356
P1476
In vitro activity of ceftaroli ...... the CANWARD surveillance study
@en
P2093
Andrew J Walkty
Daryl J Hoban
Heather J Adam
James A Karlowsky
Melanie R Baxter
Philippe R S Lagacé-Wiens
P2860
P304
P356
10.1128/AAC.01485-13
P407
P577
2013-08-26T00:00:00Z